http://www.johnjasonfallows.com/2017/07/31/new-cancer-clinical-trial-the-immune-checkpoint-inhibitor-pembrolizumab-in-combination-with-oral-decitabine-and-tetrahydrouridine-as-first-line-therapy-for-inoperable-locally-advanced-or-metastatic-2/